The book compares workplace testing outside the US including protocols, attitude surveys,and legislation from Europe, Australia and South America. The book also offers analytical information for biological matrices other than urine.

Using sample protocols from the transportation and nuclear power industries, Workplace Drug Testing reviews current federal regulations and mandatory guidelines for federal workplace testing programs and demonstrates practical techniques for specimen collection and laboratory testing. The book compares workplace testing outside the US including protocols, attitude surveys,and legislation from Europe, Australia and South America. Chapter include analytical approaches for sample testing such as radioimmunoassay and enzyme immunoassay, as well as confirmatory testing via quality assurance, calibrators, and controls. The book also offers analytical information for biological matrices other than urine; details the procedures for using hair, oral fluid, and sweat; and examines the physiologic considerations when interpreting alternative matrix test results. Containing numerous tables and figures, expert data, and supported by extensive references, this is a crucial tool for those charged with maintaining a drug-free workplace.

Chapter 1 Introduction: Drugs in the Workplace

Yale H. Caplan, Ph.D., DABFT and Marilyn A. Huestis, Ph.D.

Chapter 2 Overview of the Mandatory Guidelines for Federal Workplace Drug Testing Programs

Donna M. Bush, Ph.D., DABFT

Chapter 3 The U.S. Department of Transportation's Workplace Testing Program

Kenneth C. Edgell, M.S.

Chapter 4 Drug Testing in the Nuclear Power Industry: The NRC Fitness-for-Duty Rules

Theodore E Shults, J.D., M.S.

Chapter 5 Workplace Drug Testing outside the U.S

Anya Pierce, M.Sc., M.B.A.

Chapter 6 Analytical Considerations and Approaches for Drugs

Daniel S. Isenschmid, Ph.D. and Bruce A. Goldberger, Ph.D.

Chapter 7 Analytical Approaches for Drugs in Biological Matrices Other Than Urine..

Pascal Kintz, Pharm.D., Ph.D., Marion Villain, M.S., and Vincent Cirimele, Ph.D.

Chapter 8 Interpreting Alternative Matrix Test Results

Edward J. Cone, Ph.D., Angela Sampson-Cone, Ph.D., and Marilyn A. Huestis, Ph.D.

Chapter 9 Specimen Validity Testing

Yale H. Caplan, Ph.D., DABFT

Chapter 10 The Role of the Medical Review Officer in Workplace Drug Testing

Joseph A. Thomasino, M.D., M.S., FACPM

Chapter 11 Quality Practices in Workplace Drug Testing

John M. Mitchell, Ph.D. and Francis M. Esposito, Ph.D.

Chapter 12 Legal Issues in Workplace Drug Testing

Theodore F. Shults, J.D., M.S.

Index